Furthermore, TGR5 agonists exhibit anti-inflammatory and neuroprotective properties, and BAs are implicated in neurodegenerative diseases [116,117,118], hepatic encephalopathy [119] and amyotrophic lateral sclerosis (ALS) [120]. The gene discussed is GPBAR1; the disease is amyotrophic lateral sclerosis.